Home › Encyclopedia › Noopept: Research Status, Identity, and Trial Data
Research / Unapproved

Noopept: Research Status, Identity, and Trial Data

Molecular formulaC17H22N2O4
Molecular weight318.4 g/mol
Registered trials0
PubChem CID180496

Regulatory status

Noopept is an unapproved research compound. It does not have an FDA-approved label, and no approved indications, dosing, or safety information exist for it through that pathway.

What noopept is

Noopept is a synthetic small molecule with the chemical formula C17H22N2O4 and a molecular weight of about 318.4. Its PubChem entry (CID 180496) lists a defined structure, but no approved drug label is associated with the compound. Because no label exists, there is no FDA-described mechanism of action, drug class, or approved use to report.

Trial footprint

There are no registered trials for noopept in the dataset reviewed here. No trial titles, phases, or statuses are available to summarize at this time.

FAQ

Is noopept FDA approved?
No. Noopept is classified as an unapproved research compound and has no FDA-approved label, indication, or dosing guidance.
What is noopept chemically?
Noopept is a synthetic small molecule with the molecular formula C17H22N2O4 and a molecular weight of approximately 318.4. It is catalogued in PubChem under CID 180496.
Are there clinical trials studying noopept?
Based on the data reviewed, there are no registered clinical trials for noopept. This means there is no clinical trial evidence currently available to summarize.
What are the side effects of noopept?
No side effect or adverse event report data is currently available for noopept in the sources reviewed, so none can be summarized here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 180496 ClinicalTrials.gov

Updated 2026-11-07